Left column

Distribution Partners log in:

French Spanish

Select language:

Aivlosin® 17% Premix (Tylvalosin Type A Medicated Article)

Aivlosin® 17% Premix is indicated in the United States for the Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE.

Dosage and administration:

Swine in finished feed:

  • For Control of Porcine Proliferative Enteropathy
  • Prepare a Type C medicated feed containing 38.6 grams per ton (42.5 ppm) tylvalosin
  • Feed the Type C medicated finished feed containing 38.6 grams tylvalosin/ton as the sole ration for 14 consecutive days.

For more detailed information: Please consult the Pack insert as hereunder, or as per click 20160406 Approved USA - Aivlosin 17 percent premix swine ileitis label for ISI.pdf.

Pack Insert Details

AIVLOSIN® 17% Premix (Tylvalosin Type A Medicated Article)

  • Use only as directed.
  • For use in swine feed only.
  • Not for use in lactating or pregnant females, or males and females intended for breeding.

CAUTION:

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian

  • Do not feed undiluted.
  • For further manufacturing only.
  • For use in swine feed only.

ACTIVE DRUG INGREDIENT:

Tylvalosin 17% w/w (77.12 g tylvalosin/lb, equivalent to tylvalosin tartrate 19.4% w/w)

INDICATION:

Swine:

Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE.

DIRECTIONS FOR USE:

MIXING DIRECTIONS:

Swine:

Control of Porcine Proliferative Enteropathy

Preparation of Type B medicated feed containing 3,856 grams per ton (4,250 ppm) tylvalosin:

Prepare tylvalosin Type B medicated feed in mash form only.

To manufacture one ton of Type B medicated feed containing Medicated Article with 1950 pounds of non-medicated feed.

Preparation of Type C medicated feed containing 38.6 grams per ton (42.5 ppm) tylvalosin:

To manufacture one ton of Type C medicated feed containing 38.6 g/ton (42.5 ppm) tylvalosin, mix 0.5 pound of Aivlosin® 17% Type A Medicated Article with 1999.5 pounds of non-medicated feed.

To aid in the even distribution of drug in the finished feed, add the full amount of Aivlosin® 17% Type A Medicated Article into a small portion of the feed and mix. Blend this mixture into the remainder of the feed and mix thoroughly. Pelleted or crumbled Type C medicated feeds must bear an expiration date of 1 week after the date of manufacture.

FEEDING DIRECTIONS:

Feed Type C medicated feed containing 38.6 grams tylvalosin/ton as the sole ration for 14 consecutive days.

CAUTION:

To assure both food safety and responsible use in swine, concurrent use of tylvalosin Type A medicated article in medicated feed and tylvalosin or another macrolide in medicated drinking water or by any other route of administration should be avoided. Not for use in swine intended for breeding. The effects of tylvalosin on swine reproductive performance, pregnancy, and lactation have not been determined. VFDs for tylvalosin shall not be refilled.

WARNINGS:

WITHDRAWAL PERIOD:

No withdrawal period is required before slaughter for human consumption.

ANTIBACTERIAL WARNINGS:

Use of antibacterial drugs in the absence of a susceptible bacterial infection is unlikely to provide benefit to treated animals and may increase the development of drug-resistant bacteria.

USER SAFETY WARNINGS:

  • Not for use in humans. Keep out of reach of children.
  • May cause skin irritation. Tylvalosin has been shown to cause hypersensitivity reactions in laboratory animals.
  • People with known hypersensitivity to tylvalosin should avoid contact with this product. In case of accidental ingestion or inhalation, seek medical attention. When handling Aivlosin® 17% Type A Medicated Article and preparing medicated feeds, avoid direct contact with the eyes and skin. Wear a dust mask, coveralls and impervious gloves when mixing and handling this product. Eye protection is recommended. In case of accidental eye exposure, wash eyes immediately with water and seek medical attention. If wearing contact lenses, immediately rinse the eyes first, then remove contact lenses and continue to rinse the eyes thoroughly and seek medical attention.
  • In case of accidental skin exposure, wash contaminated skin thoroughly.
  • The Safety Data Sheet contains more detailed occupational safety information.

STORAGE:

Store in a cool dry place at or below 25°C (77°F).

NETT CONTENTS:

50 lb (22.7 kg).50 lb (22.7 kg) - Use only directed

DISTRIBUTED IN THE USA BY:

Pharmgate Animal Health.

1015 Ashes Drive, Wilmington, NC 28405.

For sales, technical assistance or to obtain a Safety Data Sheet, call Pharmgate Animal Health at 1-800-380-6099

To report suspected adverse drug events, contact the ASPCA Animal Product Safety Service at 1-800-345-4735 or the FDA at 1-888-FDA-VETS.

Pharmgate Animal Health has contracted with the ASPCA Animal Product Safety Service to collect human and animal suspected adverse drug events reports for this product.

Eco

Quality through economy

Right column